On May 26, 2017, Avadel Pharmaceuticals plc (the “Company”)
furnished to the holders of its ordinary shares and American
Depositary Shares (ADSs) the notice of the Company’s 2017
annual general meeting of shareholders to be held on June 28,
2017 (the “Meeting”), together with (i) the proxy statement
relating to the matters to be considered at the Meeting and
containing certain other information, (ii) either a proxy card
(for use by holders of the Company’s ordinary shares) or a
voting instruction card (for use by holders of the Company’s
ADSs), as applicable, and (iii) a copy of the Company’s Annual
Report on Form 10-K for the fiscal year ended December 31,
2016. The aforementioned proxy materials were furnished under
cover of a letter, a copy of which is furnished as Exhibit 99.1
to this current report on Form 8-K and is incorporated herein
by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits